MT2023-36: A Postmarketing, Prospective, Multicenter, Observational, Long-Term Safety and EffectivenessRegistry Study of Patients with Cerebral Adrenoleukodystrophy (CALD) Treated with ElivaldogeneAutotemcel (Stargazer)

Project: Research project

Project Details

Description

MT2023-36: A Postmarketing, Prospective, Multicenter, Observational, Long-Term Safety and Effectiveness Registry Study of Patients with Cerebral Adrenoleukodystrophy (CALD) Treated with Elivaldogene Autotemcel (Stargazer)
StatusActive
Effective start/end date9/14/239/30/33

Funding

  • BLUEBIRD BIO, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.